Toll-like receptor 3 activation affects serotonin transporter activity and expression in human enterocyte-like caco-2 cells

Cellular Physiology and Biochemistry

Volumn 30, Issue 1, 2012, Pages 187-198

  Mendoza, Carmen ^a   Matheus, Nyurky ^a   Latorre, Eva ^a   Castro, Marta ^a   Mesonero, Jos Emilio ^a   Alcalde, Ana Isabel ^a,b  

^a UNIVERSITY OF ZARAGOZA   (Spain)

^b UNIVERSIDAD DE ZARAGOZA   (Spain)

Author keywords

5 HT; Caco 2 cells; Intestine; Serotonin transporter; TLR3

Indexed keywords

CYCLIC AMP; DOUBLE STRANDED RNA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; POLYINOSINIC POLYCYTIDYLIC ACID; PROTEIN KINASE C; PROTEIN KINASE R; SEROTONIN; SEROTONIN TRANSPORTER; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR 3;

APICAL MEMBRANE; ARTICLE; BASEMENT MEMBRANE; CELL STRAIN CACO 2; CONTROLLED STUDY; ENZYME ACTIVITY; EPITHELIUM CELL; EXTRACELLULAR SPACE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; INTRACELLULAR TRANSPORT; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN DEPLETION; PROTEIN EXPRESSION; RECEPTOR BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSLATION REGULATION; WESTERN BLOTTING;

EID: 84863436974     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000339057     Document Type: Article

References (44)

1. Arruebo MP, Mesonero JE, Murillo MD, Alcalde AI: Effect of serotonin on D-galactose transport across the rabbit jejunum. Reprod Nutr Dev 1989;29:441-448. (Pubitemid 20060298)
2. Salvador MT, Murillo MD, Rodriguez-Yoldi MC, Alcalde AI, Mesonero JE, Rodriguez-Yoldi MJ: Effects of serotonin on the physiology of the rabbit small intestine. Can J Physiol Pharmacol 2000;78:359-366. (Pubitemid 30354458)
3. Hansen MB, Witte AB: The role of serotonin in intestinal luminal sensing and secretion. Acta Physiol 2008;193:311-323.
4. O'Hara JR, Ho W, Linden DR, Mawe GM, Sharkey KA: Enteroendocrine cells and 5-HT availability are altered in mucosa of guinea pig with TNBS ileitis. Am J Physiol Gastrointest Liver Physiol 2004;287:G998-G1007. (Pubitemid 39423692)
5. Bertrand PP, Barajas-Espinosa A, Neshat S, Bertrand RL, Lomax AE: Analysis of real-time serotonin (5-HT) availability during experimental colitis in mouse. Am J Physiol Gastrointest Liver Physiol 2010;298:G446-G455.
6. El-Salhy M, Danielsson A, Stenling R, Grimelius L: Colonic endocrine cells in inflammatory bowel disease. J Intern Med 1997;242:413-419. (Pubitemid 27513108)
7. Cremon C, Carini G, Wang B, Vasina V, Cogliandro RF, De Giorgio R, Stanghellini V, Grundy D, Tonini M, De Ponti F, Corinaldesi R, Barbara G: Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome. Am J Gastroenterol 2011;106:1290-1298.
8. Faure C, Patey N, Gauthier C, Brooks EM, Mawe GM: Serotonin signaling is altered in irritable bowel syndrome with diarrhea but not in functional dyspepsia in pediatric age patients. Gastroenterology 2010;139:249-258.
9. Foley KF, Pantano C, Ciolino A, Mawe GM: IFN-y and TNF-a decrease serotonin transporter function and expression in Caco2 cells. Am J Physiol Gastrointest Liver Physiol 2007;292:G779-G784. (Pubitemid 46440381)
10. Matheus N, Mendoza C, Iceta R, Mesonero JE, Alcalde AI: Regulation of serotonin transporter activity by adenosine in intestinal epithelial cells. Biochem Pharmacol 2009;78:1198-1204.
11. Matheus N, Mendoza C, Iceta R, Mesonero JE, Alcalde AI: Melatonin inhibits serotonin transporter activity in intestinal epithelial cells. J Pineal Res 2010;48:332-339.
12. Linden DR, Foley KF, McQuoid C, Simpson J, Sharkey KA, Mawe GM: Serotonin transporter function and expression are reduced in mice with TNBS-induced colitis. Neurogastroenterol Motil 2005;17:565-574. (Pubitemid 41075999)
13. Wheatcroft J, Wakelin D, Smith A, Mahoney CR, Mawe G, Spiller R: Enterochromaffin cell hyperplasia and decreased serotonin transporter in a mouse model of postinfectious bowel dysfunction. Neurogastroenterol Motil 2005;17:863-870. (Pubitemid 41748282)
14. Bischoff SC, Mailer R, Pabst 0, Weier G, Sedlik W, Li Z, Chen JJ, Murphy DL, Gershon MD: Role of serotonin in intestinal inflammation: knockout of serotonin reuptake transporter exacerbates 2,4,6-trinitrobenzene sulfonic acid colitis in mice. Am J Physiol Gastrointest Liver Physiol 2009;296:G685-G695.
15. Coates MD, Mahoney CR, Linden DR, Sampson JE, Chen J, Blaszyk H, Crowell MD, Sharkey KA, Gershon MD, Mawe GM, Moses PL: Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology 2004;126:1657-1664. (Pubitemid 38736329)
16. Khan WI, Ghia JE: Gut hormones: emerging role in immune activation and inflammation. Clin Exp Immunol 2010;161:19-27.
17. Haub S, Ritze Y, Bergjheim I, Pabst 0, Gershon MD, Bischoff SC: Enhancement of intestinal inflammation in mice lacking interleukin 10 by deletion of the serotonin reuptake transporter. Neurogastroenterol Motil 2010;22:826-834.
18. Lebeis SL, Bommarius B, Parkos CA, Sherman MA, Kalman D: TLR signaling mediated by MyD88 is required for a protective innate immune response by neutrophils to Citrobacter rodentium. J Immunol 2007;179:566-577. (Pubitemid 46986574)
19. Cario E, Podolsky DK: Differential alteration in epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun 2000;68:7010-7017. (Pubitemid 32463415)
20. Rakoff-Nahoum S, Paglino J , Eslami-Varzaneh F, Edberg S, Medzhitov R: Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004;118:229-241. (Pubitemid 38962578)
21. Cario E: Toll-like receptors in inflammatory bowel diseases: a decade later. Inflamm Bowel Dis 2010;16:1583-1597.
22. Vijay-Kumar M, Gentsch JR, Kaiser W J , Borregaard N, Offermann MK, Neish AS, Gewirtz AT: Protein kinase R mediates intestinal epithelial gene remodeling in response to double-stranded RNA and live rotavirus. J Immunol 2005;174:6322-6331. (Pubitemid 40663825)
23. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA: Recognition of double-stranded RNA and activation of NF-KB by Toll-like receptor 3. Nature 2001;413:732-738. (Pubitemid 33009951)
24. Vijay-Kumar M, Wu H, Aitken J , Kolachala VL, Neish AS, Sitaraman SV, Gewirtz AT: Activation of toll-like receptor 3 protects against DSS-induced acute colitis. Inflamm Bowel Dis 2007;13:856-864. (Pubitemid 47203863)
25. Cario E: Therapeutic impact of toll-like receptors on inflammatory bowel diseases: a multiple-edged sword. Inflamm Bowel Dis 2008;14:411-421. (Pubitemid 351441332)
26. Iceta R, Mesonero JE, Aramayona J J , Alcalde AI: Molecular characterization and intracellular regulation of the human serotonin transporter in Caco-2 cells. J Physiol Pharmacol 2006;57:119-130.
27. Iceta R, Mesonero JE, Alcalde AI: Effect of long-term fluoxetine treatment on the human serotonin transporter in Caco-2 cells. Life Sci 2007;80:1517-1524. (Pubitemid 46399752)
28. Iceta R, Aramayona J J , Mesonero JE, Alcalde AI: Regulation of the human serotonin transporter mediated by long-term action of serotonin in Caco-2 cells. Acta Physiol 2008;193:57-65. (Pubitemid 351490262)
29. Chantret I, Rodolosse A, Barbat A, Dussaulx E, Brot-Laroche E, Zweibaum A, Rousset M: Differential expression of sucrase-isomaltase in clones isolated from early and late passages of the cell line Caco-2: evidence for glucose-dependent negative regulation. J Cell Sci 1994;107:213-225. (Pubitemid 24039048)
30. Schaefer TM, Desouza K, Fahey JV, Beagley KW, Wira CR: Toll-like receptor (TLR) expression and TLR-mediated cytokine/chemokine production by human uterine epithelial cells. Immunology 2004; 112:428-436. (Pubitemid 38859521)
31. Furrie E, Macfarlane S, Thomson G, Macfarlane GT: Toll-like receptors-2,-3 and-4 expression patterns on human colon and their regulation by mucosal-associated bacteria. Immunology 2005;115:565-574. (Pubitemid 41032444)
32. Sato A, Iizuka M, Nakagomi O, Suzuki M, Horie Y, Konno S, Hirasawa F, Sasaki K, Shindo K, Watanabe S: Rotavirus double-stranded RNA induces apoptosis and diminishes wound repair in rat intestinal epithelial cells. J Gastroenterol Hepatol 2006;21:521-530.
33. Zhou R, Wei H, Sun R, Tian Z: Recognition of double-stranded RNA by TLR3 induces severe small intestinal injury in mice. J Immunol 2007;178:4548-4556. (Pubitemid 46492407)
34. Williams BR: Role of the double-stranded RNA-activated protein kinase (PKR) in cell regulation. Biochem Soc Trans 1997;25:509-513. (Pubitemid 27260861)
35. Paone A, Starace D, Galli R, Padula F, De Cesaris P, Filippini A, Ziparo E, Riccioli A: Toll-like receptor 3 triggers apoptosis of human prostate cancer cells through a PKC- A-dependent mechanism. Carcinogenesis 2008;29:1334-1342.
36. Wang J , Hu Y, Deng WW, Sun B: Negative regulation of Toll-like receptor signalling pathway. Microbes Infect 2009;11:321-327
37. Mendoza C, Matheus N, Iceta R, Mesonero JE, Alcalde AI: Lipopolysaccharide induces alteration of serotonin transporter in human intestinal epithelial cells. Innate Immun 2009;15:243-250.
38. Jiang Z, Zamanian-Daryoush M, Nie H, Silva AM, Williams BR, Li X: Poly(I-C)-induced Toll-like receptor 3 (TLR3)-mediated activation of NFKB and MAP kinase is through an interleukin-1 receptor-associated kinase (IRAK)-independent pathway employing the signaling components TLR3-TRAF6-TAK1-TAB2-PKR. J Biol Chem 2003;278:16713-16719. (Pubitemid 36799536)
39. Kalali BN, Kollisch G, Mages J, Miiller T, Bauer S, Wagner H, Ring J, Lang R, Mempel M, Ollert M: Double-stranded RNA induces an antiviral defense status in epidermal keratinocytes through TLR3-, PKR-, and MDA5/RIG-I-mediated differential signaling. J Immunol 2008;181:2694-2704.
40. Garcia MA, Gil J, Ventoso I, Guerra S, Domingo E, Rivas C, Esteban M: Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action. Microbiol Mol Biol Rev 2006;70:1032-1060. (Pubitemid 44958263)
41. Takeuchi 0, Akira S: MDA5/RIG-I and virus recognition. Curr Opin Immunol 2008;20:17-22.
42. Abe Y, Fujii K, Nagata N, Takeuchi 0, Akira S, Oshiumi H, Matsumoto M, Seya T, Koike S: The toll-like receptor 3 mediated antiviral response is important for protection against poliovirus infection in poliovirus receptor transgenic mice. J Virol 2012;86:185-194.
43. Zhu CB, Carneiro AM, Dostmann WR, Hewlett WA, Blakely RD: p38 MAPK activation elevates serotonin transport activity via trafficking-independent, protein phosphatase 2A-dependent process. J Biol Chem 2005;280:15649-15658. (Pubitemid 40616683)
44. Prasad HC, Zhu CB, McCauley JL, Samuvel D J , Ramamoorthy S, Shelton RC, Hewlett WA, Sutcliffe JS, Blakely RD: Human serotonin transporter variants display altered sensitivity to protein kinase G and p38 mitogen-activated protein kinase. Proc Natl Acad Sci USA 2005;102:11545-11550. (Pubitemid 41153856)